On the Record · Sinovac Biotech
Sinovac Biotech competitors, on the record
The companies Sinovac Biotech itself names as competitors in its annual reports, 2023 to 2025, each with the sentence it appears in and the filing it came from.
Who Sinovac Biotech names
| Company | Named in |
|---|---|
| AIM Vaccine | 2025 |
| CNBG | 2025 |
| GSK | 2025 |
| IMBCAMS | 2025 |
| Merck | 2025 |
| Pukang Biological | 2025 |
In its own words
AIM Vaccine, CNBG, GSK, IMBCAMS, Merck, Pukang Biological
Word for word“Our direct competitors in the PRC and global markets by product category include: • Hepatitis A: AIM Vaccine, IMBCAMS, Pukang Biological, CNBG (Domestic); GSK, Merck (International).” 20-F for 2025
Read from Sinovac Biotech’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-06-05. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.